Mikkel Pedersen, based in Denmark, is currently a Chief Scientific Officer at ComMIT Biologics. Mikkel Pedersen brings experience from previous roles at Analona Therapeutics, ComMIT Biologics, Nykode Therapeutics and Servier. Mikkel Pedersen holds a 2000 - 2003 PhD in Cancer @ Copenhagen University. With a robust skill set that includes Cell, Antibodies, Drug Discovery, In Vitro, Cell Biology and more. Mikkel Pedersen has 2 emails on RocketReach.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.